Circadia Gets FDA Nod for AI-Powered Respiratory Monitor


Startup Circadia Technologies Ltd. has received U.S. Food and Drug Administration approval for a bedside device that remotely monitors breathing using artificial intelligence and that has been shown to help detect Covid-19 symptoms such as breathlessness.

The U.K.-based company, doing business as Circadia Health, said the device is designed for use in skilled nursing facilities as well as post-acute care, and it can work from as far as 8 feet away.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: